Sorafenib suppresses the epithelial-mesenchymal transition of hepatocellular carcinoma cells after insufficient radiofrequency ablation

BACKGROUND: Epithelial-mesenchymal transition (EMT) played an important role in the progression of hepatocellular carcinoma (HCC) after insufficient radiofrequency ablation (RFA). However, whether sorafenib could be used to suppress the EMT of HCC after insufficient RFA and further prevent the progr...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:BMC Cancer
Päätekijät: Dong, Shuying, Kong, Jian, Kong, Fandong, Kong, Jinge, Gao, Jun, Ji, Liang, Pan, Bing, Chen, Lian, Zheng, Lemin, Sun, Wenbing
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BioMed Central 2015
Aiheet:
Research Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4663721/
https://ncbi.nlm.nih.gov/pubmed/26620566
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-015-1949-7
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia